The sensitivity of cells to ABT-199 in FL was predicted by the BCL-2/BIM ratio55, while in MCL by the BCL-2/(BCL-xL + MCL-1) mRNA ratio56. This evidence concerns the gene BCL2L1 and mantle cell lymphoma.